A Clinical Practice Guideline for Treating Tobacco Use and Dependence: 2008 Update. A U.S. Public Health Service Report

American Journal of Preventive Medicine

Volumn 35, Issue 2, 2008, Pages 158-176

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CLONIDINE; NICOTINE GUM; NICOTINE PATCH; NORTRIPTYLINE; PAROXETINE; VARENICLINE; VENLAFAXINE;

ABNORMAL DREAMING; CLINICAL PRACTICE; DEPRESSION; DYSPEPSIA; ECONOMIC ASPECT; EVIDENCE BASED MEDICINE; HEALTH CARE ORGANIZATION; HEALTH SERVICE; HEARTBURN; HUMAN; INSOMNIA; MENTAL DISEASE; MOUTH INFLAMMATION; NAUSEA; NOSE IRRITATION; PRACTICE GUIDELINE; REVIEW; SEIZURE; SKIN MANIFESTATION; THROAT IRRITATION; TOBACCO DEPENDENCE; XEROSTOMIA;

COUNSELING; HUMANS; META-ANALYSIS AS TOPIC; MOTIVATION; NICOTINE; PRACTICE GUIDELINES AS TOPIC; SMOKING CESSATION; TOBACCO USE DISORDER; UNITED STATES; UNITED STATES AGENCY FOR HEALTHCARE RESEARCH AND QUALITY; UNITED STATES PUBLIC HEALTH SERVICE;

EID: 46249118363     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2008.04.009     Document Type: Review

References (147)

1. USDHHS. The health consequences of smoking: a report of the Surgeon General (2004), USDHHS, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta GA
2. Rothemich S.F., Woolf S.H., Johnson R.E., et al. Effect on cessation counseling of documenting smoking status as a routine vital sign: an ACORN study. Ann Fam Med 6 (2008) 60-68
3. USDHHS. Reducing tobacco use: a report of the Surgeon General (2000), USDHHS, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta GA
4. Baumeister S.E., Schumann A., Meyer C., John U., Volzke H., and Alte D. Effects of smoking cessation on health care use: is elevated risk of hospitalization among former smokers attributable to smoking-related morbidity?. Drug Alcohol Depend 88 (2007) 197-203
5. Lightwood J. The economics of smoking and cardiovascular disease. Prog Cardiovasc Dis 46 (2003) 39-78
6. Lightwood J.M., and Glantz S.A. Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation 96 (1997) 1089-1096
7. Rasmussen S.R., Prescott E., Sorensen T.I., and Sogaard J. The total lifetime health cost savings of smoking cessation to society. Eur J Public Health 15 (2005) 601-606
8. Hurley S.F. Short-term impact of smoking cessation on myocardial infarction and stroke hospitalisations and costs in Australia. Med J Aust 183 (2005) 13-17
9. Critchley J., and Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 1 (2004) CD003041
10. Ford E.S., Ajani U.A., Croft J.B., et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 356 (2007) 2388-2398
11. CDC. Cigarette smoking among adults-United States, 2004. MMWR 54 (2005) 1121-1124
12. CDC. Cigarette smoking among adults-United States, 2004. MMWR 54 (2005) 509-513
13. Fiore M.C., Bailey W.C., and Cohen S.J. A clinical practice guideline for treating tobacco use and dependence: a U.S. Public Health Service report. JAMA 283 (2000) 3244-3254
14. Tobacco Cessation Leadership Network. Trends in the delivery and reimbursement of tobacco-dependence treatment. Available at: www.coreoptions.com/new_site/jcahocore.html.
15. CDC. State Medicaid coverage for tobacco-dependence treatments-United States, 2005. MMWR 55 (2006) 1194-1197
16. Bellows N.M., McMenamin S.B., and Halpin H.A. Adoption of system strategies for tobacco cessation by state Medicaid programs. Med Care 45 (2007) 350-356
17. Fiore M.C., Jaen C.R., and Baker T.B. Treating tobacco use and dependence: 2008 update (2008), USDHHS, U.S. Public Health Service, Rockville MD
18. American Psychiatric Association. Practice guideline for the treatment of patients with nicotine dependence. Am J Psychiatry 153 10S (1996) S1-S31
19. Kleber H.D., Weiss R.D., Anton Jr. R.F., et al. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry 164 4S (2007) 5-123 Apr
20. American Medical Association. American Medical Association guidelines for the diagnosis and treatment of nicotine dependence: how to help patients stop smoking (1994), American Medical Association, Washington, DC
21. American Dental Association. Summary of policy and recommendations regarding tobacco. Available at: www.ada.org/prof/resources/positions/statements/tobac.asp.
22. American Nurses Association. Position statements: cessation of tobacco use. Available at: nursingworld.org/readroom/position/social/sctbco.htm.
23. IOM. Ending the tobacco problem: a blueprint for the nation (2007), The National Academies Press, Washington DC
24. West R., McNeill A., and Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax 55 (2000) 987-999
25. CDC. Cigarette smoking among adults-United States, 2006. MMWR 56 (2007) 1157-1161
26. Cummings K.M., and Hyland A. Impact of nicotine replacement therapy on smoking behavior. Annu Rev Public Health 26 (2005) 583-599
27. USDHHS. Healthy people 2000: national health promotion and disease prevention objectives (1995), USDHHS, Public Health Service, Washington DC
28. Egger M., Juni P., Bartlett C., Holenstein F., and Sterne J. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews?. Empirical study. Health Technol Assess 7 (2003) 1-76
29. Terrin N., Schmid C.H., Lau J., and Olkin I. Adjusting for publication bias in the presence of heterogeneity. Stat Med 22 (2003) 2113-2126
30. National Institute on Drug Abuse. NIDA InfoFacts: cigarettes and other tobacco products. Available at: www.drugabuse.gov/Infofacts/Tobacco.html.
31. CDC. Physician and other health-care professional counseling of smokers to quit-United States, 1991. MMWR 42 (1993) 854-857
32. Drilea S.K., Reid B.C., Li C.H., Hyman J.J., and Manski R.J. Dental visits among smoking and nonsmoking U.S. adults in 2000. Am J Health Behav 29 (2005) 462-471
33. CDC. Cigarette smoking among adults-United States, 2000. MMWR 51 (2002) 642-645
34. Fu S.S., Partin M.R., Snyder A., et al. Promoting repeat tobacco-dependence treatment: are relapsed smokers interested?. Am J Manag Care 12 (2006) 235-243
35. National Cancer Institute. Tobacco and the clinician: interventions for medical and dental practice (1994) Monograph No. 5. NIH Publication No. 94-3696
36. Kreuter M.W., Chheda S.G., and Bull F.C. How does physician advice influence patient behavior?. Evidence for a priming effect. Arch Fam Med 9 (2000) 426-433
37. Richmond R.L. Physicians can make a difference with smokers: evidence-based clinical approaches. Presentation given during the Symposium on Smoking Cessation at the 29th World Conference of the IUATLD/UICTMR and Global Congress on Lung Health, Bangkok, Thailand, 23-26 November 1998. International Union Against Tuberculosis and Lung Disease. Int J Tuberc Lung Dis 3 (1999) 100-112
38. Whitlock E.P., Orleans C.T., Pender N., and Allan J. Evaluating primary care behavioral counseling interventions: an evidence-based approach. Am J Prev Med 22 (2002) 267-284
39. Tessaro I., Lyna P.R., Rimer B.K., et al. Readiness to change smoking behavior in a community health center population. J Community Health 22 (1997) 15-31
40. Ossip-Klein D.J., McIntosh S., Utman C., Burton K., Spada J., and Guido J. Smokers ages 50+: who gets physician advice to quit?. Prev Med 31 (2000) 364-369
41. Fiore M.C. Treating tobacco use and dependence: an introduction to the U.S. Public Health Service Clinical Practice Guideline. Respir Car 45 (2000) 1196-1199
42. Glynn T.J., and Manley M.W. How to help your patients stop smoking: a National Cancer Institute manual for physicians (1997) Bethesda MD: NIH Publication No. 89-3064
43. Manley M.W., Epps R.P., and Glynn T.J. The clinician's role in promoting smoking cessation among clinic patients. Med Clin North Am 76 (1992) 477-494
44. Kottke T.E., Solberg L.I., and Brekke M.L. Beyond efficacy testing: introducing preventive cardiology into primary care. Am J Prev Med 6 2S (1990) 77-83
45. Kottke T.E., and Solberg L.I. Beyond efficacy testing redux. Am J Prev Med 27 2S (2004) 104-105
46. National Cancer Institute. How to help your patients stop using tobacco: a National Cancer Institute manual for the oral health team (1993) Bethesda MD: NIH Publication No. 93-3191
47. Jordan T.R., Dake J.R., and Price J.H. Best practices for smoking cessation in pregnancy: do obstetrician/gynecologists use them in practice?. J Womens Health (Larchmt) 15 (2006) 400-441
48. Schroeder S.A. What to do with a patient who smokes. JAMA 294 (2005) 482-487
49. Goldstein M.G., Whitlock E.P., and DePue J. Multiple behavioral risk factor interventions in primary care. Summary of research evidence. Am J Prev Med 27 2S (2004) 61-79
50. Orleans C.T., Woolf S.H., Rothemich S.F., Marks J.S., and Isham G.J. The top priority: building a better system for tobacco-cessation counseling. Am J Prev Med 31 (2006) 103-106
51. American Academy of Family Physicians. Tobacco cessation. Available at www.askandact.org.
52. Gourlay S.G., Forbes A., Marriner T., Pethica D., and McNeil J.J. Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. BMJ 311 (1995) 363-366
53. Tonnesen P., Norregaard J., Sawe U., and Simonsen K. Recycling with nicotine patches in smoking cessation. Addiction 88 (1993) 533-539
54. Gonzales D.H., Nides M.A., Ferry L.H., et al. Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study. Clin Pharmacol Ther 69 (2001) 438-444
55. Hatsukami D., Mooney M., Murphy S., LeSage M., Babb D., and Hecht S. Effects of high dose transdermal nicotine replacement in cigarette smokers. Pharmacol Biochem Behav 86 (2007) 132-139
56. Herrera N., Franco R., Herrera L., Partidas A., Rolando R., and Fagerstrom K.O. Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program. Chest 108 (1995) 447-451
57. Shiffman S., Dresler C.M., Hajek P., Gilburt S.J., Targett D.A., and Strahs K.R. Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med 162 (2002) 1267-1276
58. Sweeney C.T., Fant R.V., Fagerstrom K.O., McGovern J.F., and Henningfield J.E. Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability. CNS Drugs 15 (2001) 453-467
59. Fagerstrom K.O. Combined use of nicotine replacement products. Health Values 18 (1994) 15-20
60. Shiffman S., Sweeney C.T., and Dresler C.M. Nicotine patch and lozenge are effective for women. Nicotine Tob Res 7 (2005) 119-127
61. Killen J.D., Fortmann S.P., Varady A., and Kraemer H.C. Do men outperform women in smoking cessation trials?. Maybe, but not by much. Exp Clin Psychopharmacol 10 (2002) 295-301
62. Wetter D.W., Fiore M.C., Young T.B., McClure J.B., de Moor C.A., and Baker T.B. Gender differences in response to nicotine replacement therapy: objective and subjective indexes of tobacco withdrawal. Exp Clin Psychopharmacol 7 (1999) 135-144
63. Cepeda-Benito A., Reynoso J.T., and Erath S. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women. J Consult Clin Psychol 72 (2004) 712-722
64. Mahrer-Imhof R., Froelicher E.S., Li W.W., Parker K.M., and Benowitz N. Women's Initiative for Nonsmoking (WINS V): under-use of nicotine replacement therapy. Heart Lung 31 (2002) 368-373
65. Perkins K.A. Smoking cessation in women. Special considerations. CNS Drugs 15 (2001) 391-411
66. Munafo M., Bradburn M., Bowes L., and David S. Are there sex differences in transdermal nicotine replacement therapy patch efficacy?. A meta-analysis. Nicotine Tob Res 6 (2004) 769-776
67. Perkins KA, Scott MA. Sex differences in long-term smoking cessation rates due to nicotine patch. In press.
68. Hughes J.R., Stead L.F., and Lancaster T. Nortriptyline for smoking cessation: a review. Nicotine Tob Res 7 (2005) 491-499
69. Cox L.S., Patten C.A., Niaura R.S., et al. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression. J Gen Intern Med 19 (2004) 828-834
70. Hall S.M., Reus V.I., Munoz R.F., et al. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry 55 (1998) 683-690
71. Hayford K.E., Patten C.A., Rummans T.A., et al. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Med Psychol 174 (1999) 173-178
72. Lerman C., Niaura R., Collins B.N., et al. Effect of bupropion on depression symptoms in a smoking cessation clinical trial. Psychol Addict Behav 18 (2004) 362-366
73. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75 (1988) 800-803
74. Rundmo T., Smedslund G., and Gotestam K.G. Motivation for smoking cessation among the Norwegian public. Addict Behav 22 (1997) 377-386
75. Alberg A.J., Carter C.L., and Carpenter M.J. Weight gain as an impediment to cigarette smoking cessation: a lingering problem in need of solutions. Prev Med 44 (2007) 296-297
76. Donze J., Ruffieux C., and Cornuz J. Determinants of smoking and cessation in older women. Age Ageing 36 (2007) 53-57
77. Fagan P., Augustson E., Backinger C.L., et al. Quit attempts and intention to quit cigarette smoking among young adults in the United States. Am J Public Health 97 (2007) 1412-1420
78. Miller W.R., and Rollnick S. Motivational interviewing: preparing people for change. 2nd ed. (2002), Guilford Press, New York
79. Carpenter M.J., Hughes J.R., Solomon L.J., and Callas P.W. Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. J Consult Clin Psychol 72 (2004) 371-381
80. Chan S.S., Lam T.H., Salili F., et al. A randomized controlled trial of an individualized motivational intervention on smoking cessation for parents of sick children: a pilot study. Appl Nurs Res 18 (2005) 178-181
81. Butler C.C., Rollnick S., Cohen D., Bachmann M., Russell I., and Stott N. Motivational consulting versus brief advice for smokers in general practice: a randomized trial. Br J Gen Pract 49 (1999) 611-616
82. Curry S.J., Ludman E.J., Graham E., Stout J., Grothaus L., and Lozano P. Pediatric-based smoking cessation intervention for low-income women: a randomized trial. Arch Pediatr Adolesc Med 157 (2003) 295-302
83. Brown R.A., Ramsey S.E., Strong D.R., et al. Effects of motivational interviewing on smoking cessation in adolescents with psychiatric disorders. Tob Control 12 Suppl 4 (2003) IV3-IV10
84. Steinberg M.L., Ziedonis D.M., Krejci J.A., and Brandon T.H. Motivational interviewing with personalized feedback: a brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. J Consult Clin Psychol 72 (2004) 723-728
85. Hettema J., Steele J., and Miller W.R. Motivational interviewing. Annu Rev Clin Psychol 1 (2005) 91-111
86. Ahluwalia J.S., Okuyemi K., Nollen N., et al. The effects of nicotine gum and counseling among African American light smokers: a 2 x 2 factorial design. Addiction 101 (2006) 883-891
87. Amrhein P.C., Miller W.R., Yahne C.E., Palmer M., and Fulcher L. Client commitment language during motivational interviewing predicts drug use outcomes. J Consult Clin Psychol 71 (2003) 862-878
88. Rollnick S., Miller W.R., and Butler C.C. Motivational interviewing in health care: helping patients change behavior (2008), The Guilford Press, New York
89. Rollnick S., Mason P., and Butler C. Health behavior change: a guide for practitioners (1999), Churchill Livingstone, Edinburgh
90. Carpenter M.J., Hughes J.R., and Keely J.P. Effect of smoking reduction on later cessation: a pilot experimental study. Nicotine Tob Res 5 (2003) 155-162
91. Hughes J.R., Keely J., and Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 99 (2004) 29-38
92. Piasecki T.M., Fiore M.C., McCarthy D.E., and Baker T.B. Have we lost our way?. The need for dynamic formulations of smoking relapse proneness. Addiction 97 (2002) 1093-1108
93. Westman E.C., Behm F.M., Simel D.L., and Rose J.E. Smoking behavior on the first day of a quit attempt predicts long-term abstinence. Arch Intern Med 157 (1997) 333-340
94. Haddock C.K., O'Byrne K.K., Klesges R.C., Talcott W., Lando H., and Peterson A.L. Relapse to smoking after basic military training in the U.S. Air Force. Mil Med 165 (2000) 884-888
95. Krall E.A., Garvey A.J., and Garcia R.I. Smoking relapse after 2 years of abstinence: findings from the VA Normative Aging Study. Nicotine Tob Res 4 (2002) 95-100
96. Wetter D.W., Cofta-Gunn L., Fouladi R.T., Cinciripini P.M., Sui D., and Gritz E.R. Late relapse/sustained abstinence among former smokers: a longitudinal study. Prev Med 39 (2004) 1156-1163
97. Hajek P., Stead L.F., West R., and Jarvis M. Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev 1 (2005) CD003999
98. Brandon T.H., Collins B.N., Juliano L.M., and Lazev A.B. Preventing relapse among former smokers: a comparison of minimal interventions through telephone and mail. J Consult Clin Psychol 68 (2000) 103-113
99. Brandon T.H., Meade C.D., Herzog T.A., Chirikos T.N., Webb M.S., and Cantor A.B. Efficacy and cost-effectiveness of a minimal intervention to prevent smoking relapse: dismantling the effects of amount of content versus contact. J Consult Clin Psychol 72 (2004) 797-808
100. Alterman A.I., Gariti P., and Mulvaney F. Short- and long-term smoking cessation for three levels of intensity of behavioral treatment. Psychol Addict Behav 15 (2001) 261-264
101. Barth J., Critchley J., and Bengel J. Efficacy of psychosocial interventions for smoking cessation in patients with coronary heart disease: a systematic review and meta-analysis. Ann Behav Med 32 (2006) 10-20
102. Grandes G., Cortada J.M., Arrazola A., and Laka J.P. Predictors of long-term outcome of a smoking cessation programme in primary care. Br J Gen Pract 53 (2003) 101-107
103. Hilleman D.E., Mohiuddin S.M., and Packard K.A. Comparison of conservative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery. Chest 125 (2004) 435-438
104. Pisinger C., Vestbo J., Borch-Johnsen K., and Jorgensen T. Smoking cessation intervention in a large randomised population-based study. The Inter99 study. Prev Med 40 (2005) 285-292
105. Rigotti N.A., Munafo M.R., Murphy M.F., and Stead L.F. Interventions for smoking cessation in hospitalized patients. Cochrane Database Syst Rev 1 (2003) 1-21 CD001837
106. Cromwell J., Bartosch W.J., Fiore M.C., Hasselblad V., and Baker T. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA 278 (1997) 1759-1766
107. Conroy M.B., Majchrzak N.E., Regan S., Silverman C.B., Schneider L.I., and Rigotti N.A. The association between patient-reported receipt of tobacco intervention at a primary care visit and smokers' satisfaction with their health care. Nicotine Tob Res 7 1S (2005) S29-S34
108. Barzilai D.A., Goodwin M.A., Zyzanski S.J., and Stange K.C. Does health habit counseling affect patient satisfaction?. Prev Med 33 (2001) 595-599
109. Stead L., Perera R., and Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev 3 (2006) CD002850
110. Bentz C.J., Bayley K.B., Bonin K.E., Fleming L., Hollis J.F., and McAfee T. The feasibility of connecting physician offices to a state-level tobacco quit line. Am J Prev Med 30 (2006) 31-37
111. Holtrop J.S., Wadland W.C., Vansen S., Weismantel D., and Fadel H. Recruiting health plan members receiving pharmacotherapy into smoking cessation counseling. Am J Manag Care 11 (2005) 501-507
112. Perry R.J., Keller P.A., Fraser D., and Fiore M.C. Fax to quit: a model for delivery of tobacco cessation services to Wisconsin residents. WMJ 104 (2005) 37-40 44
113. Winickoff J.P., Buckley V.J., Palfrey J.S., Perrin J.M., and Rigotti N.A. Intervention with parental smokers in an outpatient pediatric clinic using counseling and nicotine replacement. Pediatrics 112 (2003) 1127-1133
114. Winickoff J.P., Hillis V.J., Palfrey J.S., Perrin J.M., and Rigotti N.A. A smoking cessation intervention for parents of children who are hospitalized for respiratory illness: the Stop Tobacco Outreach Program. Pediatrics 111 (2003) 140-145
115. Carr A.B., and Ebbert J.O. Interventions for tobacco cessation in the dental setting: a systematic review. Community Dent Health 24 (2007) 70-74
116. Wewers M.E., Kidd K., Armbruster D., and Sarna L. Tobacco dependence curricula in U.S. baccalaureate and graduate nursing education. Nurs Outlook 52 (2004) 95-101
117. Pinget C., Martin E., Wasserfallen J.B., Humair J.P., and Cornuz J. Cost-effectiveness analysis of a European primary-care physician training in smoking cessation counseling. Eur J Cardiovasc Prev Rehabil 14 (2007) 451-455
118. Fiore M.C., Epps R.P., and Manley M.W. A missed opportunity: teaching medical students to help their patients successfully quit smoking. JAMA 271 (1994) 624-626
119. Spangler J.G., George G., Foley K.L., and Crandall S.J. Tobacco intervention training: current efforts and gaps in U.S. medical schools. JAMA 288 (2002) 1102-1109
120. Powers C.A., Zapka J.G., Bognar B., et al. Evaluation of current tobacco curriculum at 12 U.S. medical schools. J Cancer Educ 19 (2004) 212-219
121. Ferry L.H., Grissino L.M., and Runfola P.S. Tobacco dependence curricula in U.S. undergraduate medical education. JAMA 282 (1999) 825-829
122. Geller A.C., and Powers C.A. Medical education: teaching smoking cessation in U.S. medical schools: a long way to go. Am Med Assoc J Ethics 9 (2007) 21-25
123. Geller A.C., Zapka J., Brooks K.R., et al. Tobacco control competencies for U.S. medical students. Am J Public Health 95 (2005) 950-955
124. Weaver R.G., Whittaker L., Valachovic R.W., and Broom A. Tobacco control and prevention effort in dental education. J Dent Educ 66 (2002) 426-429
125. McCartan B.E., and Shanley D.B. Policies and practices of European dental schools in relation to smoking; a ten-year follow-up. Br Dent J 198 (2005) 423-425
126. CDC. Best Practices for Comprehensive Tobacco Control Programs-2007 (2007), USDHHS, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta GA
127. Solberg L.I., Maciosek M.V., Edwards N.M., Khanchandani H.S., and Goodman M.J. Repeated tobacco-use screening and intervention in clinical practice: health impact and cost effectiveness. Am J Prev Med 31 (2006) 62-71
128. Feenstra T.L., Hamberg-van Reenen H.H., Hoogenveen R.T., and Rutten-van Molken M.P. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study. Value Health 8 (2005) 178-190
129. Stapleton J.A., Lowin A., and Russell M.A. Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness. Lancet 354 (1999) 210-215
130. Johansson P.M., Tillgren P.E., Guldbrandsson K.A., and Lindholm L.A. A model for cost-effectiveness analyses of smoking cessation interventions applied to a Quit-and-Win contest for mothers of small children. Scand J Public Health 33 (2005) 343-352
131. Croghan I.T., Offord K.P., Evans R.W., et al. Cost-effectiveness of treating nicotine dependence: the Mayo Clinic experience. Mayo Clin Proc 72 (1997) 917-924
132. Raw M., McNeill A., and Coleman T. Lessons from the English smoking treatment services. Addiction 100 Suppl 2 (2005) 84-91
133. Parrott S., and Godfrey C. Economics of smoking cessation. BMJ 328 (2004) 947-949
134. Chirikos T.N., Herzog T.A., Meade C.D., Webb M.S., and Brandon T.H. Cost-effectiveness analysis of a complementary health intervention: the case of smoking relapse prevention. Int J Technol Assess Health Care 20 (2004) 475-480
135. Warner K.E., Mendez D., and Smith D.G. The financial implications of coverage of smoking cessation treatment by managed care organizations. Inquiry 41 (2004) 57-69
136. Fishman P.A., Khan Z.M., Thompson E.E., and Curry S.J. Health care costs among smokers, former smokers, and never smokers in an HMO. Health Serv Res 38 (2003) 733-749
137. Fishman P.A., Thompson E.E., Merikle E., and Curry S.J. Changes in health care costs before and after smoking cessation. Nicotine Tob Res 8 (2006) 393-401
138. Musich S., Faruzzi S.D., Lu C., McDonald T., Hirschland D., and Edington D.W. Pattern of medical charges after quitting smoking among those with and without arthritis, allergies, or back pain. Am J Health Promot 18 (2003) 133-142
139. Martinson B.C., O'Connor P.J., Pronk N.P., and Rolnick S.J. Smoking cessation attempts in relation to prior health care charges: the effect of antecedent smoking-related symptoms?. Am J Health Promot 18 (2003) 125-132
140. Wagner E.H., Curry S.J., Grothaus L., Saunders K.W., and McBride C.M. The impact of smoking and quitting on health care use. Arch Intern Med 155 (1995) 1789-1795
141. Warner K.E., Smith R.J., Smith D.G., and Fries B.E. Health and economic implications of a work-site smoking-cessation program: a simulation analysis. J Occup Environ Med 38 (1996) 981-992
142. Halpern M.T., Khan Z.M., Young T.L., and Battista C. Economic model of sustained-release bupropion hydrochloride in health plan and work site smoking-cessation programs. Am J Health Syst Pharm 57 (2000) 1421-1429
143. Halpern M.T., Shikiar R., Rentz A.M., and Khan Z.M. Impact of smoking status on workplace absenteeism and productivity. Tob Control 10 (2001) 233-238
144. Halpern M.T., Dirani R., and Schmier J.K. Impacts of a smoking cessation benefit among employed populations. J Occup Environ Med 49 (2007) 11-21
145. Curry S.J., Grothaus L.C., McAfee T., and Pabiniak C. Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization. N Engl J Med 339 (1998) 673-679
146. Burns M.E., Rosenberg M.A., and Fiore M.C. Use and employer costs of a pharmacotherapy smoking-cessation treatment benefit. Am J Prev Med 32 (2007) 139-142
147. Schauffler H.H., McMenamin S., Olson K., Boyce-Smith G., Rideout J.A., and Kamil J. Variations in treatment benefits influence smoking cessation: results of a randomised controlled trial. Tob Control 10 (2001) 175-180